IL3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Integra Lifesciences Holdings Corp

Watchlist Manager

Watchlist

Price: 9.6 EUR 5.49%

Market Cap: €2B

I	Integra Lifesciences Holdings Corp SWB:IL3	US
	Innate Pharma SA PAR:IPH	FR
	Koninklijke BAM Groep NV AEX:BAMNB	NL
	Mitsubishi Estate Co Ltd TSE:8802	JP
C	CNH Industrial NV DUS:37C	UK
	Unity Software Inc NYSE:U	US
	Innate Pharma SA NASDAQ:IPHA	FR
I	Innate Pharma SA SWB:IDD	FR
	Hindustan Aeronautics Ltd NSE:HAL	IN

Profitability Summary

Integra Lifesciences Holdings Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

63% > 57%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

13%

Declining Operating Margin

18% > 11%

Negative Net Margin

-30%

Negative 3Y Average Net Margin

-8%

Declining Net Margin

8% > -30%

Negative Free Cash Flow Margin

-1%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

10% > -1%

Negative ROE

-39%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.